KUALA LUMPUR (Bernama) -- Bursa Malaysia Derivatives Bhd will be launching an after-hours (T+1) trading session (Night Trading) by the fourth quarter of 2021 to enhance the attractiveness of the Malaysian derivatives market to traders around the world.
Available for most Bursa Malaysia Derivatives products, Night Trading is a significant development that aligns the exchange with global market practices, said the exchange in a statement.
It is set to enhance price discovery of Bursa Malaysia Derivatives’ offerings given the substantial growth in derivatives market participation since 2019.
Last year, the total number of contracts traded registered a 35 per cent growth, increasing to 18.2 million contracts from 13.5 million contracts in 2019, with foreign participants contributing 46 per cent of the total trading volume.
On June 30, 2021, the total monthly trading volume for the exchange’s Crude Palm Oil Futures contract (FCPO) renewed its all-time high at 1.7 million contracts, which is equivalent to 42.6 million tonnes of crude palm oil traded, surpassing the previous record of 1.66 million contracts traded in March 2020.
"The recent volatility in crude palm oil prices demonstrated the need for Night Trading. It will provide an avenue for market participants to better manage their price risk exposure based on real-time global developments in different time zones.
"We will continue to work with our stakeholders to ensure smooth implementation of the Night Trading,” said Bursa Malaysia Derivatives chief executive officer Samuel Ho.
Bursa Malaysia Derivatives recently received approval-in-principal (AIP) from the Securities Commission Malaysia to operate Night Trading.
"Enhancing the trading ecosystem will help sustain the strong interest and promote further internationalisation of the Malaysian derivatives market.
"Market participants can look forward to more infrastructure enhancement projects which will be rolled out in stages later this year,” added Ho.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
